Peptide exceptionalism is a dangerous FDA loophole. Demand evidence, not hype

The US is hooked on unregulated peptides. But are they effective, or even safe?

The US is hooked on unregulated peptides. But are they effective, or even safe?

Restrictions could be lifted on peptides loved by wellness influencers

Unproven peptides touting wellness have been relegated to a gray market because of Biden-era restrictions. Under the Trump administration, that could change.

GLP-1 Use Reaches Record High as Access Broadens, New Data Shows

(NaturalNews) The share of Americans using glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss has surged to unprecedented levels, according to report...

When the FDA panel on peptides meets next month, rest assured that the health of the nation will be guarded by the finest experts money can buy [Murica]

[link] [14 comments]

FDA to Review Easing Restrictions on Peptides

This summer the FDA will consider loosening restrictions on certain peptide injections, with encouragement from RFK Jr. and the Trump administration. Bloomberg Businessweek senior reporter Amanda Mull explains to hosts David Gura and Christina Ruffini how peptides are popular among wellness enthusiasts and biohackers, who claim they offer benefits ranging from treating tendonitis to enhancing tanning. (Source: Bloomberg)

Ivermectin isn't a cancer miracle drug, but influencers claim otherwise -- here's how to avoid sprinting past scientific evidence

Ivermectin isn't a cancer miracle drug, but influencers claim otherwise -- here's how to avoid sprinting past scientific evidence

NervGen Pharma: I Think The Biggest Risks Are Now Behind It

NervGen Pharma: I Think The Biggest Risks Are Now Behind It

Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?

This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

FDA staff question peptides backed by Kennedy ahead of advisory panel review

FDA staff question peptides backed by Kennedy ahead of advisory panel review

FDA Scientists Warn Against Peptides Kennedy Backs as He Reshapes the Advisory Panel

FDA scientists concluded that none of the seven peptides Health Secretary Kennedy wants available through compounding pharmacies have sufficient human evidence for expanded access. The findings arrived alongside Kennedy's appointment of nine new panel members with financial ties to the peptide industry.

FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports

Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.

Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know

If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.

Need More Protein and Fiber? This Delicious (And Clean) Bar Is the Solution

Sponsored content. Us Weekly receives compensation for this article as well as for purchases made when you click on a link and buy something below. If you think you’re seeing these protein bars everywhere, that’s because you are. People are tired of dense, chalky textures, sugary add-ins and artificial ingredients, which is why they’re turning []

WEGOVY THE WONDER DRUG

Lose weight, reduce the risk of CV disease – unless you are taking Wegovy? [A tale of mystery and intrigue unfolds]. A lot of people have asked me about the weight loss drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 agonists) e.g. Wegovy (semaglutide), or Mounjaro (tirzepatide). What do I think of them, are they []

Your Gut May Be Hiding More Cancer-Fighting Potential Than We Knew

A probiotic strain may have a secret superpower

Peptide That Makes You Tan Linked to Skin Cancer, Doctor Warns

I don't really see a medical benefit of it at all. The post Peptide That Makes You Tan Linked to Skin Cancer, Doctor Warns appeared first on Futurism.

Vera Therapeutics stock jumps after the FDA approved its autoimmune kidney drug

Trutakna, priced at 425,000 per year, is the first drug approved in the U.S. that targets both BAFF and APRIL proteins linked to IgA nephropathy

Gynaecologist reveals the most common misconceptions about fibroids - and why 'benign' doesn't mean 'harmless'

Gynaecologist reveals the most common misconceptions about fibroids - and why 'benign' doesn't mean 'harmless'

Comprehensive guide on weight loss using GLP-1 medications: Here’s a detailed list!

Glucagon-like peptide-1 (GLP-1) therapies have offered clinically proven weight-loss and metabolic benefits. We know that obesity is a relapsing and chronic ailment that has affected more than 1 billion individuals across the world. Hence, knowing what to do makes all the difference. What are GLP-1 agonists in brief? These are classes of medicines that are usually...

Alpha-gal syndrome red meat allergy from ticks

Doctronic reports that alpha-gal syndrome, triggered by lone star tick bites, causes delayed allergic reactions to red meat, posing growing health concerns.

Is Donald Trump on a Wonder Weight Loss Drug? Here’s What You Need to Know.

Let us answer your questions about a slightly serious—but deeply amusing—medical mystery.

Bryan Johnson: Millionaire biohacker behind Project Blueprint diagnosed with incurable autoimmune disease

A multi-millionaire biohacker who is on a quest to ‘defeat death’ has been diagnosed with a rare incurable disease.

RPG Life Sciences launches Naprosyn ES, a first-in-India Naproxen-Esomeprazole combination

The product targets patients on long-term NSAID therapy who face elevated risk of gastrointestinal complications.

Maharashtra FDA Acts Against Cadila Pharma; Bars Sale Of Two Sets Of Medicines

FDA Commissioner Tukaram Mundhe said confusion caused by similar brand names, which could lead doctors, pharmacists or patients to administer the wrong drug, amounted to a serious public health...

Ozempic Face, Blindness Claims, And Billions In Potential Damages: The GLP-1 Reckoning

Ozempic Lawsuits 2026 Side Effects 2B Claims Image by Radoslaw MaciejewskiShutterstock (1)A surge in demand for GLP-1 receptor agonist drugs su...

‘Big changes’: Crick to stop paying for hybrid open access

Leading biomedical research institute says it will “go full in on green and gold” The post ‘Big changes’: Crick to stop paying for hybrid open access appeared first on Research Professional News.